Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein–Ligand Complexes

Journal of Medicinal Chemistry
2015.0

Abstract

Multipolar interactions involving fluorine and the protein backbone have been frequently observed in protein-ligand complexes. Such fluorine-backbone interactions may substantially contribute to the high affinity of small molecule inhibitors. Here we found that introduction of trifluoromethyl groups into two different sites in the thienopyrimidine class of menin-MLL inhibitors considerably improved their inhibitory activity. In both cases, trifluoromethyl groups are engaged in short interactions with the backbone of menin. In order to understand the effect of fluorine, we synthesized a series of analogues by systematically changing the number of fluorine atoms, and we determined high-resolution crystal structures of the complexes with menin. We found that introduction of fluorine at favorable geometry for interactions with backbone carbonyls may improve the activity of menin-MLL inhibitors as much as 5- to 10-fold. In order to facilitate the design of multipolar fluorine-backbone interactions in protein-ligand complexes, we developed a computational algorithm named FMAP, which calculates fluorophilic sites in proximity to the protein backbone. We demonstrated that FMAP could be used to rationalize improvement in the activity of known protein inhibitors upon introduction of fluorine. Furthermore, FMAP may also represent a valuable tool for designing new fluorine substitutions and support ligand optimization in drug discovery projects. Analysis of the menin-MLL inhibitor complexes revealed that the backbone in secondary structures is particularly accessible to the interactions with fluorine. Considering that secondary structure elements are frequently exposed at protein interfaces, we postulate that multipolar fluorine-backbone interactions may represent a particularly attractive approach to improve inhibitors of protein-protein interactions.

Knowledge Graph

Similar Paper

Rational Design of Orthogonal Multipolar Interactions with Fluorine in Protein–Ligand Complexes
Journal of Medicinal Chemistry 2015.0
Design and synthesis of benzylpiperidine inhibitors targeting the menin–MLL1 interface
Bioorganic & Medicinal Chemistry Letters 2016.0
Theoretical models of inhibitory activity for inhibitors of protein–protein interactions: targeting menin–mixed lineage leukemia with small molecules
MedChemComm 2017.0
Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase B
European Journal of Medicinal Chemistry 2012.0
Design of HIV-1 Protease Inhibitors with Pyrrolidinones and Oxazolidinones as Novel P1′-Ligands To Enhance Backbone-Binding Interactions with Protease: Synthesis, Biological Evaluation, and Protein−Ligand X-ray Studies
Journal of Medicinal Chemistry 2009.0
Progress towards small molecule menin-mixed lineage leukemia (MLL) interaction inhibitors with in vivo utility
Bioorganic & Medicinal Chemistry Letters 2015.0
Interaction of Antagonists with Calmodulin: Insights from Molecular Dynamics Simulations
Journal of Medicinal Chemistry 2008.0
Bridgehead modification of trihalocycloheptabenzopyridine lead to a potent farnesyl protein transferase inhibitor with improved oral metabolic stability
Bioorganic & Medicinal Chemistry Letters 2004.0
Optimisation of the P2 pharmacophore in a series of thrombin inhibitors: Ion-dipole interactions with lysine 60G
Bioorganic & Medicinal Chemistry Letters 1999.0
Design of HIV-1 Protease Inhibitors with C3-Substituted Hexahydrocyclopentafuranyl Urethanes as P2-Ligands: Synthesis, Biological Evaluation, and Protein–Ligand X-ray Crystal Structure
Journal of Medicinal Chemistry 2011.0